0001104659-18-043867.txt : 20180703 0001104659-18-043867.hdr.sgml : 20180703 20180703165658 ACCESSION NUMBER: 0001104659-18-043867 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180601 FILED AS OF DATE: 20180703 DATE AS OF CHANGE: 20180703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Witz Pascale CENTRAL INDEX KEY: 0001703723 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-35587 FILM NUMBER: 18938170 MAIL ADDRESS: STREET 1: C/O REGULUS THERAPEUTICS INC. STREET 2: 10614 SCIENCE CENTER DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TESARO, Inc. CENTRAL INDEX KEY: 0001491576 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 272249687 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1000 WINTER STREET, SUITE 3300 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: (339) 970-0900 MAIL ADDRESS: STREET 1: 1000 WINTER STREET, SUITE 3300 CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: Tesaro, Inc. DATE OF NAME CHANGE: 20100510 4/A 1 a4a.xml 4/A X0306 4/A 2018-06-01 2018-06-05 0 0001491576 TESARO, Inc. TSRO 0001703723 Witz Pascale C/O TESARO, INC. 1000 WINTER STREET WALTHAM MA 02451 1 0 0 0 Common Stock 2018-06-01 4 A 0 1279 0 A 1279 D Director Nonqualified Stock Option (right to buy) 46.89 2018-06-01 4 A 0 14221 0 A 2028-06-01 Common Stock 14221 14221 D Director Restricted Stock Units 2018-06-01 4 A 0 8104 0 A Common Stock 8104 8104 D The Reporting Person has elected to receive common stock in lieu of cash for board retainers and fees otherwise payable in cash. The option vests in three annual installments beginning on June 1, 2019, subject to the Reporting Person's continued service on the Issuer's board of directors. Each restricted stock unit ("RSU") represents a contingent right to receive one share of TESARO common stock. The RSUs vest in three annual installments beginning on June 1, 2019, subject to the Reporting Person's continued service on the Issuer's board of directors. This amendment is being filed to amend the Form 4 filed by the reporting person on June 5, 2018 (the "Original Form 4") for the sole purpose of correcting the numbers of derivative securities acquired as reported in column 5 of Table II of the Original Form 4, the numbers of shares underlying securities as reported in column 7 of Table II of the Original Form 4, and the numbers of derivative securities beneficially owned following the reported transactions as reported in column 9 of Table II of the Original Form 4. /s/ Joseph L. Farmer, Attorney-in-Fact 2018-07-03